EP2398486A4 - Zusammensetzungen und verfahren zur prävention und/oder behandlung von krebs mit pa-card - Google Patents

Zusammensetzungen und verfahren zur prävention und/oder behandlung von krebs mit pa-card

Info

Publication number
EP2398486A4
EP2398486A4 EP10744428A EP10744428A EP2398486A4 EP 2398486 A4 EP2398486 A4 EP 2398486A4 EP 10744428 A EP10744428 A EP 10744428A EP 10744428 A EP10744428 A EP 10744428A EP 2398486 A4 EP2398486 A4 EP 2398486A4
Authority
EP
European Patent Office
Prior art keywords
card
compositions
methods
prevent
treat cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10744428A
Other languages
English (en)
French (fr)
Other versions
EP2398486A1 (de
Inventor
Gupta Tapas Das
Ananda Chakrabarty
Arsenio Fialho
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CDG Therapeutics Inc
Original Assignee
CDG Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CDG Therapeutics Inc filed Critical CDG Therapeutics Inc
Publication of EP2398486A1 publication Critical patent/EP2398486A1/de
Publication of EP2398486A4 publication Critical patent/EP2398486A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP10744428A 2009-02-20 2010-02-22 Zusammensetzungen und verfahren zur prävention und/oder behandlung von krebs mit pa-card Withdrawn EP2398486A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15423609P 2009-02-20 2009-02-20
US17943509P 2009-05-19 2009-05-19
PCT/US2010/024904 WO2010096754A1 (en) 2009-02-20 2010-02-22 Compositions and methods to prevent and/or treat cancer with pa -card

Publications (2)

Publication Number Publication Date
EP2398486A1 EP2398486A1 (de) 2011-12-28
EP2398486A4 true EP2398486A4 (de) 2012-11-21

Family

ID=42634238

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10744428A Withdrawn EP2398486A4 (de) 2009-02-20 2010-02-22 Zusammensetzungen und verfahren zur prävention und/oder behandlung von krebs mit pa-card

Country Status (9)

Country Link
EP (1) EP2398486A4 (de)
JP (1) JP2012518417A (de)
KR (1) KR20120000062A (de)
CN (1) CN102387809A (de)
AU (1) AU2010215858A1 (de)
CA (1) CA2753121A1 (de)
IL (1) IL214757A0 (de)
SG (1) SG174136A1 (de)
WO (1) WO2010096754A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1959986B1 (de) 2005-11-07 2014-07-23 Indiana University Research and Technology Corporation Glucagon-analoga mit physiologischer löslichkeit und stabilität
WO2014049604A2 (en) * 2012-09-05 2014-04-03 Amrita Therapeutics Limited A novel biomedical device for cancer therapy
KR101764750B1 (ko) * 2013-02-05 2017-08-03 애그리컬쳐럴 테크놀로지 리서치 인스티튜트 항-마이코플라즈마 에스피피. 아단위 백신
CN103554187B (zh) * 2013-09-18 2016-03-30 中国科学技术大学 铂类配合物、由该铂类化合物制得的蛋白质复合物及其制备方法
USD844857S1 (en) * 2017-10-05 2019-04-02 Western Interlock, Inc. Retaining wall corner block

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020164703A1 (en) * 2000-12-21 2002-11-07 Krzysztof Pawlowski Card-domain containing polypeptides, encoding nucleic acids, and methods of use
WO2003097085A1 (en) * 2002-05-16 2003-11-27 University College London Ddah modulators in the treatment of pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2336416T3 (es) * 1999-01-26 2010-04-13 University College London Dimetilarginina dimetilaminohidrolasa.
BRPI0515850A (pt) * 2004-10-07 2008-08-12 Ananda Chakrabarty agentes de transportes derivados de cupredoxina e métodos de uso dos mesmos

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020164703A1 (en) * 2000-12-21 2002-11-07 Krzysztof Pawlowski Card-domain containing polypeptides, encoding nucleic acids, and methods of use
WO2003097085A1 (en) * 2002-05-16 2003-11-27 University College London Ddah modulators in the treatment of pain

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NI ET AL: "Arginine deiminase, a potential anti-tumor drug", CANCER LETTERS, NEW YORK, NY, US, vol. 261, no. 1, 7 January 2008 (2008-01-07), pages 1 - 11, XP022458995, ISSN: 0304-3835 *
See also references of WO2010096754A1 *

Also Published As

Publication number Publication date
EP2398486A1 (de) 2011-12-28
CA2753121A1 (en) 2010-08-26
IL214757A0 (en) 2011-11-30
SG174136A1 (en) 2011-10-28
CN102387809A (zh) 2012-03-21
AU2010215858A1 (en) 2011-09-22
WO2010096754A8 (en) 2011-04-28
JP2012518417A (ja) 2012-08-16
KR20120000062A (ko) 2012-01-03
WO2010096754A1 (en) 2010-08-26

Similar Documents

Publication Publication Date Title
IL218987A0 (en) Methods and compositions for treating cancer
IL239918A0 (en) Preparations for the treatment of colitis
EP2419137A4 (de) Zusammensetzungen und verfahren zur behandlung von akuter myelogener leukämie
IL218212A0 (en) Therapeutic methods and compositions
ZA200905508B (en) Compositions and methods to prevent cancer with cupredoxins
HK1159498A1 (en) Methods and compositions for the treatment of cancer
EP2419136A4 (de) Zusammensetzungen und verfahren zur behandlung von krebs
SG10201500124VA (en) Methods and Compositions for Treating Cancer
EP2504428A4 (de) Verfahren und zusammensetzungen zur behandlung oxalat-vermittelter leiden
EP2429584A4 (de) Behandlungsverfahren und -zusammensetzungen
IL214500A0 (en) Compositions and methods for extended therapy with aminopyridines
EP2340027A4 (de) Verfahren und zusammensetzungen zur behandlung von krebs
IL215932A0 (en) Compositions and methods for treating burns
IL214349A0 (en) Compositions and methods for the treatment of cancer
GB0903299D0 (en) Composition and methods
EP2437738A4 (de) Verfahren und zusammensetzungen zur krebsbehandlung
IL214757A0 (en) Compositions and methods to prevent and/or treat cancer with pa-card
IL213636A0 (en) Compositions and methods to prevent cancer with cupredoxins
GB0901494D0 (en) Compositions and Methods
EP2411031A4 (de) Verfahren und zusammensetzungen zur behandlung von krebs
EP2461870A4 (de) Therapeutische zusammensetzungen und verfahren
IL213657A0 (en) Compositions and methods to prevent cancer with cupredoxins
IL213919A0 (en) Methods to treat cancer
EP2582384A4 (de) Zusammensetzungen und verfahren zur behandlung von krebs
EP2537031A4 (de) Zusammensetzungen und verfahren zur behandlung von krebs

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110920

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20121024

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/48 20060101AFI20121019BHEP

Ipc: A61P 35/00 20060101ALI20121019BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130523